Which is the most active single chemotherapeutic agent in the treatment of Leiomyosarcoma –
**Core Concept**
Leiomyosarcoma is a malignant smooth muscle tumor that requires targeted chemotherapy. The effectiveness of chemotherapy agents in treating leiomyosarcoma depends on their ability to inhibit tumor cell growth and proliferation.
**Why the Correct Answer is Right**
Doxorubicin is an anthracycline antibiotic that intercalates DNA strands, thereby inhibiting the synthesis of nucleic acids and inducing apoptosis in cancer cells. Its high lipophilicity allows it to penetrate tumor cells effectively, making it a potent chemotherapeutic agent for leiomyosarcoma. Doxorubicin also induces topoisomerase II-mediated DNA damage, further contributing to its cytotoxic effects.
**Why Each Wrong Option is Incorrect**
**Option A:** Vincristine is a vinca alkaloid that primarily acts on microtubules, inhibiting cell division. Although it is effective against various types of cancer, its mechanism of action does not specifically target leiomyosarcoma cells.
**Option B:** Cisplatin is a platinum-based chemotherapeutic agent that induces DNA cross-linking, thereby inhibiting DNA repair and cell proliferation. However, it is not the most active single agent in treating leiomyosarcoma.
**Option C:** Ifosfamide is an alkylating agent that induces DNA cross-linking and interstrand cross-linking, leading to apoptosis in cancer cells. While it has some activity against leiomyosarcoma, it is not as effective as doxorubicin.
**Clinical Pearl / High-Yield Fact**
Doxorubicin is a commonly used chemotherapeutic agent for various types of sarcomas, including leiomyosarcoma. However, its use is limited by its cardiotoxic effects, which can lead to cardiac dysfunction and congestive heart failure.
**Correct Answer: D. Doxorubicin**